hexamethylene bisacetamide has been researched along with sb 202190 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beaven, MA; Chaves-Dias, C; Cunha-Melo, JR; Gilfillan, AM; Hundley, TR; Kirshenbaum, AS; Metcalfe, DD | 1 |
Blank, V; Carrière, L; Derjuga, A; Gasiorek, J; Mardini, L; Paw, BH; Ponka, P; Schranzhofer, M | 1 |
2 other study(ies) available for hexamethylene bisacetamide and sb 202190
Article | Year |
---|---|
Induction of telomerase activity during development of human mast cells from peripheral blood CD34+ cells: comparisons with tumor mast-cell lines.
Topics: Acetamides; Androstadienes; Animals; Antigens, CD34; CD13 Antigens; Cell Cycle; Cell Differentiation; Cell Division; Cell Line; Cells, Cultured; Drug Synergism; Enzyme Activation; Enzyme Induction; Enzyme Inhibitors; Growth Inhibitors; Growth Substances; Humans; Imidazoles; Interleukin-3; Interleukin-6; Leukemia, Basophilic, Acute; Mast Cells; Protein Kinase Inhibitors; Protein Synthesis Inhibitors; Proto-Oncogene Proteins c-kit; Pyridines; Rats; Stem Cell Factor; Telomerase; Tumor Cells, Cultured; Wortmannin | 2001 |
Antagonistic roles of the ERK and p38 MAPK signalling pathways in globin expression, haem biosynthesis and iron uptake.
Topics: Acetamides; Animals; Antineoplastic Agents; Blotting, Northern; Butadienes; Cell Differentiation; Cell Line, Tumor; Enzyme Inhibitors; Gene Expression; Globins; Heme; Hemoglobins; Imidazoles; Immunoblotting; Iron; MAP Kinase Signaling System; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Nitriles; p38 Mitogen-Activated Protein Kinases; Pyridines | 2010 |